ÂÜÀòÂÒÂ×

Dr. Glass is the President of D. Glass Associates, Inc., is a consultant specializing in industrial biotechnology regulatory affairs, with over 30 years’ experience with government regulation of the commercial uses of modified microorganisms and plants. Dr. Glass recently served as director of regulatory affairs for Joule Unlimited Technologies, where he managed the successful submission of the first Microbial Commercial Activity Notice (MCAN) for industrial use of a genetically modified strain of cyanobacteria. Earlier in his career, Dr. Glass directed intellectual property and regulatory affairs for BioTechnica International, where he obtained government approvals for some of the earliest U.S. field tests of genetically modified microorganisms and transgenic plants. As a consultant, Dr. Glass has advised agricultural, environmental, and industrial biotechnology companies on the impact of EPA, USDA, FDA and international regulations on their activities, facilitated consultations with regulatory agencies, and he has coordinated the preparation and submission of six MCANs, a New Pathway Petition under the Renewable Fuel Standard, an AAFCO Animal Feed Ingredient Definition Application, and other regulatory applications. Dr. Glass also has 25 years experience in academic technology transfer, having held leadership positions at Massachusetts General Hospital, Joslin Diabetes Center, and the University of Massachusetts system. Dr. Glass holds a B.S. in biological sciences from Cornell University and a Ph.D. in biochemical sciences from Princeton University.